• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Have the New Tdap Vaccine Recommendations Impacted Infant Pertussis Hospitalizations?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • In 2012 ACIP recommended that all pregnant women receive the Tdap vaccine, even if previously vaccinated
  • Boulet et al. (JAMA, 2019) investigated trends in pertussis hospitalizations in the US among infants younger than 2 months before and after the changes to the recommendations in 2012

METHODS:

  • Data sources
    • Truven Health Analytics Marketscan Commercial databases
    • Deidentified patient-level data from employer-sponsored private health insurance
  • Population
    • Mothers with private employer sponsored insurance delivered between 2009 and 2017
  • Study design and data analysis
    • Pertussis hospitalization: Defined as inpatient admission with report of a pertussis-related code
    • Monthly pertussis hospitalization rates: Calculated by dividing the total number of hospitalizations with a pertussis diagnosis in the first 2 months of life by the total number of infants younger than 2 months during a given month
    • Risk ratios (RRs) and 95% CIs for infant pertussis hospitalizations were calculated to compare 2 different time periods
      • 2009-2012 period
      • 2013-2017 period
  • Primary outcome
    • Pertussis hospitalization occurring between the date of birth and 2 months of age

RESULTS:

  • 1,921,892 infants
  • The rate of pertussis hospitalization decreased in the 2013-2017 period, compared to the 2009-2012 period
    • 2009-2012
      • 8.4 per 100,000 infants (95% CI, 7.2 to 9.7 per 100,000; 177 of 2.1 million infants)
    • 2013-2017
      • 3.3 per 100,000 infants (95% CI, 2.6 to 4.3 per 100,000; 57 of 1.7 million infants)

CONCLUSION:

  • Authors acknowledge limitations of this study including
    • These patients were all insured and therefore results may not be generalizable
    • Due to nature of the data, maternal Tdap vaccinations status was unknown relative to the infants
  • However, these results suggest that the recommendations has had an important impact on young infant pertussis infection rates
  • The authors state

These findings underscore the public health importance of maternal Tdap vaccination in reducing pertussis burden among young infants. Clinicians should continue to promote maternal Tdap vaccination and find ways to overcome barriers to vaccination during pregnancy

Learn More – Primary Sources:

Trends in Infant Pertussis Hospitalizations in the United States, 2009-2017

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

Learn More  »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Does Prenatal Tdap Vaccine Protect Infants From Pertussis? 
Are Tdap and Polio Vaccines Safe During Pregnancy?
Do Prenatal Tdap Vaccines Increase Risk for Autism?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site